133 related articles for article (PubMed ID: 33641836)
1. Insight into the COVID-19 led slow-down in TB notifications in India.
Golandaj JA
Indian J Tuberc; 2021 Jan; 68(1):142-145. PubMed ID: 33641836
[No Abstract] [Full Text] [Related]
2. The potential impact of the COVID-19 response related lockdown on TB incidence and mortality in India.
Bhargava A; Shewade HD
Indian J Tuberc; 2020 Dec; 67(4S):S139-S146. PubMed ID: 33308660
[TBL] [Abstract][Full Text] [Related]
3. Pediatric TB detection in the era of COVID-19.
Golandaj JA
Indian J Tuberc; 2022 Jan; 69(1):104-108. PubMed ID: 35074141
[TBL] [Abstract][Full Text] [Related]
4. The impact of the COVID-19 pandemic and associated suppression measures on the burden of tuberculosis in India.
Arentz M; Ma J; Zheng P; Vos T; Murray CJL; Kyu HH
BMC Infect Dis; 2022 Jan; 22(1):92. PubMed ID: 35086472
[TBL] [Abstract][Full Text] [Related]
5. Effects of Coronavirus Disease Pandemic on Tuberculosis Notifications, Malawi.
Soko RN; Burke RM; Feasey HRA; Sibande W; Nliwasa M; Henrion MYR; Khundi M; Dodd PJ; Ku CC; Kawalazira G; Choko AT; Divala TH; Corbett EL; MacPherson P
Emerg Infect Dis; 2021 Jul; 27(7):1831-1839. PubMed ID: 34152962
[TBL] [Abstract][Full Text] [Related]
6. Impact of COVID-19 on tuberculosis notifications.
Pontes TAA; Fernandez-Llimos F; Wiens A
Rev Inst Med Trop Sao Paulo; 2024; 66():e37. PubMed ID: 38865575
[TBL] [Abstract][Full Text] [Related]
7. Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic.
Kadota JL; Reza TF; Nalugwa T; Kityamuwesi A; Nanyunja G; Kiwanuka N; Shete P; Davis JL; Dowdy D; Turyahabwe S; Katamba A; Cattamanchi A
Int J Tuberc Lung Dis; 2020 Nov; 24(11):1212-1214. PubMed ID: 33172531
[No Abstract] [Full Text] [Related]
8. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia.
Adegbija O; Walker J; Smoll N; Khan A; Graham J; Khandaker G
Commun Dis Intell (2018); 2021 Feb; 45():. PubMed ID: 33632091
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 Pandemic on Pre-Treatment Delays, Detection, and Clinical Characteristics of Tuberculosis Patients in Ningxia Hui Autonomous Region, China.
Wang X; He W; Lei J; Liu G; Huang F; Zhao Y
Front Public Health; 2021; 9():644536. PubMed ID: 34095053
[No Abstract] [Full Text] [Related]
10. Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020.
Hasan T; Nguyen VN; Nguyen HB; Nguyen TA; Le HTT; Pham CD; Hoang N; Nguyen PTM; Beardsley J; Marks GB; Fox GJ
Emerg Infect Dis; 2022 Mar; 28(3):684-692. PubMed ID: 35202526
[TBL] [Abstract][Full Text] [Related]
11. TB control in India in the COVID era.
Behera D
Indian J Tuberc; 2021 Jan; 68(1):128-133. PubMed ID: 33641833
[TBL] [Abstract][Full Text] [Related]
12. The untimely demise of the TB Free block model in the wake of coronavirus disease 2019 in India.
Datta B; Jaiswal A; Goyal P; Prakash A; Tripathy JP; Trehan N
Trans R Soc Trop Med Hyg; 2020 Nov; 114(11):789-791. PubMed ID: 32797204
[No Abstract] [Full Text] [Related]
13. Accelerating TB notification from the private health sector in Delhi, India.
Kundu D; Chopra K; Khanna A; Babbar N; Padmini TJ
Indian J Tuberc; 2016 Jan; 63(1):8-12. PubMed ID: 27235938
[TBL] [Abstract][Full Text] [Related]
14. Challenges in TB control and the anticipated COVID-19 third wave: Way forward.
Padmapriyadarsini C; Banurekha V; Arora VK
Indian J Tuberc; 2021 Oct; 68(4):425-427. PubMed ID: 34752307
[No Abstract] [Full Text] [Related]
15. COVID-19 and tuberculosis: A mathematical model based forecasting in Delhi, India.
Marimuthu Y; Nagappa B; Sharma N; Basu S; Chopra KK
Indian J Tuberc; 2020 Apr; 67(2):177-181. PubMed ID: 32553309
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis notification in a private tertiary care teaching hospital in South India: a mixed-methods study.
Siddaiah A; Ahmed MN; Kumar AMV; D'Souza G; Wilkinson E; Maung TM; Rodrigues R
BMJ Open; 2019 Feb; 9(2):e023910. PubMed ID: 30782889
[TBL] [Abstract][Full Text] [Related]
17. Universal health coverage and tuberculosis care in India in the times of Covid-19: Aligning Ayushman Bharat (National Health Assurance Scheme) to improve case detection, reduce deaths and catastrophic health expenditure.
Bhargava A; Bhargava M; Meher A
Natl Med J India; 2020; 33(5):298-301. PubMed ID: 34213460
[TBL] [Abstract][Full Text] [Related]
18. Quantifying heterogeneity in SARS-CoV-2 transmission during the lockdown in India.
Arinaminpathy N; Das J; McCormick TH; Mukhopadhyay P; Sircar N
Epidemics; 2021 Sep; 36():100477. PubMed ID: 34171509
[TBL] [Abstract][Full Text] [Related]
19. Epidemic Landscape and Forecasting of SARS-CoV-2 in India.
Rajendrakumar AL; Nair ATN; Nangia C; Chourasia PK; Chourasia MK; Syed MG; Nair AS; Nair AB; Koya MSF
J Epidemiol Glob Health; 2021 Mar; 11(1):55-59. PubMed ID: 32959618
[TBL] [Abstract][Full Text] [Related]
20. Mortality due to TB-COVID-19 coinfection in India.
Kumar MS; Surendran D; Manu MS; Rakesh PS; Balakrishnan S
Int J Tuberc Lung Dis; 2021 Mar; 25(3):250-251. PubMed ID: 33688819
[No Abstract] [Full Text] [Related]
[Next] [New Search]
